Binder design for targeting SARS-CoV-2 spike protein: An in silico perspective

Ali Etemadi, Hamid Reza Moradi, Farideh Mohammadian, Mohammad Hossein Karimi-Jafari, Babak Negahdari, Yazdan Asgari, Mohammadali Mazloomi

Résultats de recherche: Contribution à un journalArticleRevue par des pairs

2 Citations (Scopus)

Résumé

Introduction: The COVID-19 pandemic is now affecting all people around the world and getting worse. New antiviral medications are desperately needed other than the few approved medications that have shown no promising efficacy so far. Methods: Here we report three blocking binders for targeting SARS-CoV-2 spike protein to block the interaction between the spike protein on the SARS-CoV-2 and the angiotensin-converting enzyme 2 (ACE2) receptors, responsible for viral homing into the alveolar epithelium type II cells (AECII). Results: The design process is based on the collected natural scaffolds and using Rosetta interface for designing the binders. Conclusion: Based on the structural analysis, three binders were selected, and the results showed that they might be promising as new therapeutic targets for blocking COVID-19.

langue originaleAnglais
Numéro d'article101452
journalGene Reports
Volume26
Les DOIs
étatPublié - 1 mars 2022
Modification externeOui

Contient cette citation